Purple Biotech financials at a glance

The revenue of Purple Biotech is reported as 0 billion New Shekels in the fiscal year 2023. The earnings were 0 New Shekels per share in 2023, which was 36.36 higher than 2016. And about -1.0E-5 billion New Shekels are reported as free cash flow in the financials of Purple Biotech 2023. No dividends were paid to the shareholders of the Purple Biotech stock TASE:PPBT in the financial year 2023.